Health protection – collection

Escherichia coli (E. coli): guidance, data and analysis

The characteristics, diagnosis, management, surveillance and epidemiology of Escherichia coli (E. coli).

Escherichia coli (E. coli) bacteria are frequently found in the intestines of humans and animals. There are many different types of E. coli, and while some live in the intestine quite harmlessly, others may cause a variety of diseases.

The bacterium is found in faeces and can survive in the environment. E. coli bacteria can cause a range of infections including urinary tract infection, cystitis (infection of the bladder), and intestinal infection. E. coli bacteraemia (blood stream infection) may be caused by primary infections spreading to the blood.

For guidance on E. coli O157 or VTEC see Vero cytotoxin-producing Escherichia coli (VTEC): guidance, data and analysis.

Diagnosis and management

  1. Urinary Tract Infection (UTI) diagnosis

    • Guidance

Data submission

  1. Escherichia coli bacteraemia: surveillance form

    • Form

Epidemiology

Enhanced surveillance of E. coli bacteraemia has been mandatory for NHS acute trusts since June 2011. Patient data of any E. coli bacteraemias are reported monthly to Public Health England (PHE). Independent sector healthcare organisations providing regulated activities have also undertaken surveillance of E. coli bacteraemia since June 2011.

  1. Escherichia coli (E. coli) bacteraemia: annual data

    • Statistics
  2. Escherichia coli (E. coli) bacteraemia: monthly data by NHS acute trust

    • Statistics
  3. Escherichia coli (E. coli) bacteraemia: monthly data by attributed clinical commissioning group

    • Statistics
  4. Escherichia coli bacteraemia: annual trends in voluntary surveillance

    • Research and analysis
  5. MRSA, MSSA and E. coli bacteraemia and C. difficile infection: quarterly epidemiological commentary

    • Statistics
  6. MRSA, MSSA and E. coli bacteraemia and Clostridium difficile infection: annual data for independent sector healthcare organisations

    • Statistics
  7. MRSA, MSSA and E. coli bacteraemia and C. difficile infection: annual epidemiological commentary

    • Statistics
  8. MRSA, MSSA and E. coli bacteraemia and Clostridium difficile infection: 6-monthly data for independent sector healthcare organisations

    • Statistics
  9. Pre-release access list: mandatory HCAI statistical releases

    • Guidance